SEC 13FLatest Quarter: 2026 Q3·Holdings as of 2026-09-30·~1.6 months lag (50 days)
2026 Q3 Received: 30 / 33 (3 not filed)
←Back to Directory
Farallon Capital
Manager:Thomas Steyer
● Live Quotes Active
American investment firm.
📅Filing Quarter:2026 Q3 (2026-09-30)
13F Portfolio Value (Latest Qtr)
$23.2B
Turnover
31.9%
Top 5 Concentration
44.2%
Total 13F Holdings
116
Sector Breakdown
Core Sector Coverage (4 Sectors)60.4%
Click sector to filter holdings$23.2B
📋Top 10 Holdings (of 116)
2026 Q3| Ticker / Asset | Sector | Live Price | 24h Change | Weight | Shares | Action |
|---|---|---|---|---|---|---|
SPY↗ETF SPDR S&P 500 ETF | ETF | 17.1% | 5.2M | 🔥 NEW | ||
Revolution Medicines, Inc. | Healthcare | 11.9% | 13.4M | 🔴 SELL-1.3% | ||
Warner Bros. Discovery, Inc. - | Communication Services | 6.6% | 49.4M | 🔥 NEW | ||
Natera, Inc. | Healthcare | 4.6% | 2.6M | 🟢 BUY+18.2% | ||
BridgeBio Pharma, Inc. | Healthcare | 4.0% | 14.2M | 🟢 BUY+33.1% | ||
Protagonist Therapeutics, Inc. | Healthcare | 3.9% | 6.4M | 🟢 BUY+2.2% | ||
Exelixis, Inc. | Healthcare | 3.7% | 14.7M | 🟢 BUY+8.9% | ||
Roivant Sciences Ltd. | Healthcare | 3.4% | 21.7M | 🔥 NEW | ||
Roku, Inc. | Communication Services | 2.7% | 4.2M | 🔥 NEW | ||
Amazon.com Inc. | Consumer Cyclical | 2.5% | 2.4M | 🔴 SELL-8.9% |
📈8-Quarter Holdings Evolution
Track historical shifts, entries, and exits of top holdings across the last 8 quarters
8 Quarters Matrix
| Asset / Ticker | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 8Q Net Change | Full Market Search |
|---|---|---|---|---|---|---|---|---|---|---|
| SPY↗ SPDR S&P 500 ETF | - | - | - | - | - | - | - | 17.1% | +17.1% | Whale Owners → |
| RVMD↗ Revolution Medicines, Inc. | 0.8% | 16.0% | 10.1% | 6.7% | 14.0% | 11.6% | 11.7% | 11.9% | +11.1% | Whale Owners → |
| WBD↗ Warner Bros. Discovery, Inc. - | - | - | - | - | - | - | - | 6.6% | +6.6% | Whale Owners → |
| NTRA↗ Natera, Inc. | 1.9% | 0.8% | 3.7% | 2.5% | 2.0% | 3.1% | 2.8% | 4.6% | +2.7% | Whale Owners → |
| BBIO↗ BridgeBio Pharma, Inc. | 2.1% | 6.9% | 4.6% | 3.2% | 2.6% | 4.0% | 3.7% | 4.0% | +1.9% | Whale Owners → |
| PTGX↗ Protagonist Therapeutics, Inc. | 5.0% | 2.8% | 1.4% | 4.5% | 3.4% | 3.1% | 3.6% | 3.9% | -1.1% | Whale Owners → |
| EXEL↗ Exelixis, Inc. | 5.6% | 3.4% | 1.9% | 4.8% | 3.6% | 3.1% | 3.4% | 3.7% | -1.9% | Whale Owners → |